RxDoctor Payments DataLook up a doctor →

Cara Hinckley, NP

Adult Health · Dothan, ALNPI 1346714680

Payments from drug & device makers

$8,344in general payments, 2019–2025

Across 308 payments — averaging $27.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$644
  • AstraZeneca$619
  • Johnson & Johnson$505
  • Novo Nordisk$382
  • Amgen$360
  • Lilly USA, LLC$353
  • plus $5K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation22$644
AstraZeneca(2 entities)18$619
Johnson & Johnson20$505
Novo Nordisk4$382
Amgen3$360
Lilly USA, LLC12$353
E.r. Squibb & Sons, L.L.C.11$325
Novartis14$294
Pfizer24$287
Genentech USA, Inc.14$278
Daiichi Sankyo Inc.8$262
Regeneron Healthcare Solutions, Inc.10$229
Otsuka America Pharmaceutical, Inc.2$214
Merck9$209
Exelixis Inc.6$208
Bristol Myers Squibb8$192
Genmab U.S., Inc.5$178
Takeda Pharmaceuticals U.S.A., Inc.6$138
Seagen Inc.3$138
AbbVie6$136
Gilead(2 entities)2$136
Array Biopharma Inc10$121
Myriad Genetic Laboratories, Inc.2$116
Biohaven Pharmaceuticals, Inc.1$115
Sanofi4$112
Deciphera Pharmaceuticals Inc.5$112
Pharmaessentia USA Corporation5$110
AVEO Pharmaceuticals, Inc.5$106
Eagle Pharmaceuticals, Inc.2$100
Beigene USA, Inc.5$89
Eisai Inc.4$88
Pharmacosmos Therapeutics Inc.4$88
Ipsen Biopharmaceuticals, Inc4$86
Coherus Oncology, Inc.3$71
Tersera Therapeutics LLC3$71
Scpharmaceuticals Inc.1$66
Sobi, Inc3$59
Servier Pharmaceuticals LLC3$56
Jazz Pharmaceuticals Inc.2$51
Acrotech Biopharma Inc.3$51
Stemline Therapeutics Inc.3$50
Medtronic1$50
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$47
Beone Medicines USA, Inc.2$42
HEMA Biologics, LLC2$34
Mirati Therapeutics, Inc.2$31
Kyowa Kirin, Inc.2$30
Astellas Pharma US Inc2$30
Sumitomo Pharma America, Inc.2$29
Rigel Pharmaceuticals, Inc.2$28
Spectrum Pharmaceuticals Inc.2$28
ADC Therapeutics America, Inc.1$21
Fennec Pharmaceuticals, Inc.1$19
Puma Biotechnology, Inc.1$19
Amneal Pharmaceuticals LLC1$19
G1 Therapeutics, Inc.1$19
Bayer1$19
Dendreon Pharmaceuticals LLC1$18
Blueprint Medicines Corporation1$17
Boehringer Ingelheim1$14

How this compares

$8,344 in reported general payments places this provider in the 95th percentile of 308 adult health providers in Alabama.

See all adult health providers in Alabama →

Medicare billing

Part B allowed, 2024
$23,000
Medicare patients
143
Services billed
292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Dothan

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →